Aspergillus is a fungus which occurs everywhere throughout the world. It feeds on dead animal or plant material and in this role is vitally important to the environment to recycle all kinds of biological materials. It is spread via microscopically small spores that are extremely light and float easily in the air. Normally when aspergillus spores are inhaled by people, their immune system recognises the spores as foreign and they are destroyed.


The most common sites of aspergillus infection are the respiratory apparatus (lungs, sinuses) and these infections can be:

chest X ray
Chest X-ray of patient
with CPA

Thank you to our sponsor Appliances Direct, one of the Uks largest online appliance stores. If you are looking for an Oven, Fridge, range cooker, American Fridge Freezer, gas hob or induction hob you can find some great deals. They also deal with big brands like Baumatic, Neff, Bosch, Smeg and Hotpoint.

Aspergillosis is an infection by the fungus Aspergillus. Aspergillosis describes a large number of diseases involving both infection and growth of fungus as well as allergic responses. Aspergillosis can occur in a variety of organs, both in humans and animals.
All animals and many plants have highly efficient mechanisms to prevent themselves being infected by Aspergillus, and it is usually only when those mechanisms are defective in some way that Aspergillus can grow within the body.
Further information for patients on types of aspergillosis can be found in the patient's section of this site.

The vast majority of people who may develop aspergillosis are those that have had their immune system weakened - possibly after transplant surgery or following treatments for cancer.
Alternatively aspergillosis can occur in an immunocompetent person (i.e. a person with no known suppression of their immune system) where previous tissue damage has occurred - for instance heavily scarred pulmonary tissue associated with tuberculosis, chronic obstructive pulmonary disease or bronchiectasis or some underlying lung disease. Comprehensive overview.

Invasive aspergillosis

Invasive aspergillosis normally only occurs in severely immune-compromised patients and has a high mortality rate (25-90%). Invasive disease is most commonly seen in the lungs, which is called pulmonary aspergillosis, but although less common, dissemination of aspergillus to other tissues, including the central nervous system, sinuses, bone, heart, kidney, eye, blood and skin, has been reported.
Risk factors for invasive aspergillosis include patients on steroids, chemotherapy treatment resulting in severe neutropenia, stem cell and solid organ transplantation, later stages of AIDS, and a genetic disease called chronic granulomatous disease.
Diagnosis can be made by detection of aspergillus species by biopsy, culture and microscopy of tissue samples. Chest CT scans and detection of aspergillus antigens in body fluids, by a variety of methods, all assist with diagnosis but do not give a definitive diagnosis of invasive aspergillosis.
Treatment is with antifungal drugs such as voriconazole, caspofungin, itraconazole, posaconazole, or amphotericin B. Voriconazole is usually more effective than amphotericin B; serum levels of voriconazole and itraconazole must be monitored and individually adjusted. There are many other drug interactions known for both itraconazole and voriconazole which must be considered. For comprehensive information on the diagnosis, treatment and prevention of aspergillosis and information on antifungal drugs and patient information leaflets visit the Patient Support section.

For more information on aspergillus and its diseases with a multilingual translation click here.